Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Inventia Life Science

Explore full profile

Revolutionising 3D cell biology

Sydney, AustraliaFounded 2013Biotech & Life Sciences
Valuation $0–100M Latest valuation · 2022
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Inventia Life Science and the history behind them.

About Inventia Life Science

Inventia Life Sciences specializes in developing cutting-edge solutions for creating advanced 3D cell models, which are crucial for accelerating biomedical research and drug discovery. The company serves a diverse range of clients, including researchers, pharmaceutical companies, and academic institutions, who are at the forefront of medical and scientific innovation. Operating in the biotechnology and life sciences market, Inventia leverages its proprietary technology to offer ready-to-use, xeno-free matrices that support various cell and tissue types. Their instruments feature an intuitive user experience with integrated dual HEPA filtration, making them accessible to users without coding expertise. The business model revolves around selling these advanced tools and consumables, generating revenue through direct sales and long-term partnerships with research institutions and pharmaceutical companies. Inventia's technology is also transforming skin regeneration, driving a paradigm shift in personalized clinical therapies for skin trauma. By integrating seamlessly with standard well plates and downstream analysis, their models facilitate high-quality in situ imaging and comprehensive data collection.

Source: Dealroom company data

At a glance

Founded
2013
Headquarters
Sydney, Australia
Sector
Biotech & Life Sciences

Latest news

Press, funding announcements and product moves mentioning Inventia Life Science.

See all news

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A7 investors entered at this stage

  • Skip Capital
  • Prisma Investments
  • Main Sequence Ventures
  • AirTree Ventures
  • Aware Super
  • Hostplus
  • HESTA
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States18.2%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Inventia Life Science on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Inventia Life Science on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.